Please login to the form below

Not currently logged in
Email:
Password:

Newron Pharma

This page shows the latest Newron Pharma news and features for those working in and with pharma, biotech and healthcare.

Newron back on track for Xadago approval in US

Newron back on track for Xadago approval in US

Newron Pharma will not have to conduct any additional clinical trials for its Parkinson's disease drug Xadago in the US, setting up a new FDA filing in the coming weeks. ... Now, Newron is planning to refile a marketing application with the FDA in

Latest news

  • Rare disease therapies head the ‘class of 2015’ Rare disease therapies head the ‘class of 2015’

    In 2015, a total of 44 New Molecular Entities (NMEs) were approved for marketing in countries around the world, maintaining the high output from pharma industry pipelines of the last few ... neprilysin inhibitor. Novartis. USA. safinamide. Xadago.

  • Chasing the cure for Parkinson's disease Chasing the cure for Parkinson's disease

    Generic versions of this drug combination are also available, including Parcopa (Azur Pharma). ... Currently available therapies of this class include selegiline and rasagiline. Safinamide (Newron, Zambon and Meiji Seika Pharma) is a selective and

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Newron Pharma appoints commercial affairs VP Newron Pharma appoints commercial affairs VP

    Newron Pharma appoints commercial affairs VP. Dennis Dionne brings expertise from J&J and Novartis. ... Milan, Italy-based Newron Pharmaceuticals has promoted Dennis Dionne to vice president of commercial affairs.

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health’s mission is to help our clients unlock the potential that exists with their assets, brands and organisations in...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics